MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 290 filers reported holding MIRATI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,787,659 | +27.4% | 41,039 | +5.7% | 0.10% | +32.0% |
| Q2 2023 | $1,403,072 | +19.7% | 38,834 | +23.2% | 0.08% | +4.2% |
| Q1 2023 | $1,172,174 | +347.6% | 31,527 | +445.4% | 0.07% | +323.5% |
| Q4 2022 | $261,892 | -31.3% | 5,780 | +5.9% | 0.02% | -37.0% |
| Q3 2022 | $381,000 | -0.5% | 5,457 | -4.4% | 0.03% | +12.5% |
| Q2 2022 | $383,000 | -24.8% | 5,711 | -7.7% | 0.02% | +14.3% |
| Q1 2022 | $509,000 | -49.1% | 6,190 | -9.2% | 0.02% | -36.4% |
| Q4 2021 | $1,000,000 | -24.1% | 6,816 | -8.5% | 0.03% | -25.0% |
| Q3 2021 | $1,318,000 | +488.4% | 7,450 | +469.6% | 0.04% | +388.9% |
| Q1 2021 | $224,000 | +12.0% | 1,308 | +43.4% | 0.01% | 0.0% |
| Q4 2020 | $200,000 | – | 912 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,000,000 | $31,470,000 | 8.67% |
| Baker Brothers Advisors | 2,805,074 | $88,276,000 | 0.77% |
| Broadfin Capital, LLC | 359,661 | $11,319,000 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 397,660 | $12,514,000 | 0.42% |
| Boulegeris Investments, Inc. | 17,415 | $548,000 | 0.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 95,000 | $2,990,000 | 0.29% |
| Rhenman & Partners Asset Management AB | 50,000 | $1,574,000 | 0.19% |
| Integre Asset Management, LLC | 23,996 | $755,000 | 0.16% |
| Orbimed Advisors | 680,500 | $21,415,000 | 0.16% |
| EAM Investors, LLC | 38,754 | $1,220,000 | 0.14% |